TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma
Christian Thomas(University Hospital Münster), Leonille Schweizer(Goethe University Frankfurt), Malte Träger(Humboldt-Universität zu Berlin), Georgios Ntoulias(Vivantes Klinikum), Patrick N. Harter(Ludwig-Maximilians-Universität München), Dominic Edelmann(German Cancer Research Center), Hee‐Yeong Kim(German Cancer Research Center), Alexandra Förster(Humboldt-Universität zu Berlin), Sven-Axel May(Klinikum Chemnitz), Martin Hasselblatt(University Hospital Münster), Franziska Eckert(Medical University of Vienna), Felix Thierfelder(German Cancer Research Center), David Capper(German Cancer Research Center), Jens Schittenhelm(Brain (Germany)), Carola Geiler(Humboldt-Universität zu Berlin), Werner Paulus(Institute of Neuroimmunology of the Slovak Academy of Sciences), Michael Müther, Walter Stummer(University of Münster), Katharina Filipski(Goethe University Frankfurt), Ulrich Schüller(Universität Hamburg), Julia Onken(German Society of Surgery), Frank L. Heppner(Helmholtz Association of German Research Centres), Patrick Soschinski(University Hospital Münster), David Kaul(Charité - Universitätsmedizin Berlin), Arend Koch(Charité - Universitätsmedizin Berlin), Peter Vajkoczy(Humboldt-Universität zu Berlin)
Cited by 43
Related Papers
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
|Nature Neuroscience|2020|1.5k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k